Aptose Biosciences Inc.
APTO
Revenue
0.00
0.000.00%
-Assets
11.61M
▼-9.64M▼-45.36%
12 Months ChangeLiabilities
13.13M
▲466.00k▲3.68%
3 Months ChangeFree Cash Flow
-13.53M
▼-6.55M▼-93.90%
9 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-04
Form 8-K
ID: 0001171843-24-005511
2024-09-06
Form 8-K
ID: 0001171843-24-005098
2024-09-05
Form 8-K
ID: 0001171843-24-005087
2024-08-30
Form 8-K
ID: 0001171843-24-005003
2024-08-15
Form 8-K
ID: 0001171843-24-004831
2024-08-08
Form 10-Q
ID: 0000950170-24-094205
2024-08-08
Form 8-K
ID: 0001171843-24-004614
2024-07-26
Form 8-K
ID: 0001171843-24-004181
2024-07-19
Form 8-K
ID: 0001171843-24-004037
2024-06-20
Form 8-K
ID: 0001171843-24-003548